CV risk: if you aren’t testing ACR, you aren’t seeing the full picture
Postgraduate Medicine, vol. 138, pp. 623–627
Abstract
Chronic kidney disease (CKD) remains a hidden epidemic, under-recognized and under-diagnosed, despite widespread recognition of the benefits of systematic screening of at-risk individuals and early diagnosis. CKD is an important driver of cardiovascular risk, even in the early stages before a diagnosis has been made. An elevated albumin-to-creatinine ratio is an independent cardiovascular (CV) risk factor, and importantly, it is modifiable. Inclusion of urinary albumin-to-creatine ratio testing enables detection of CV risk and CKD before estimated glomerular filtration rate declines and allows for implementation of guideline‑directed therapy at the earliest point where it is clinically indicated. Inclusion of urinary albumin-to-creatinine ratio as part of routine testing of at-risk individuals in standard practice would enable early intervention with guideline-directed medical therapies to optimize outcomes and alter disease progression. Individuals at risk of CKD include, but are not limited to, those with type 2 diabetes, CV disease, or hypertension, all conditions that can cause early, often silent, kidney damage. In these populations, measuring the urine albumin-to-creatinine ratio enables early detection of CKD and CV risk, allowing timely initiation of guideline-directed therapies to prevent disease progression. Although this podcast presents expert opinion, rather than original research, all recommendations are guideline-driven and evidence-based, rather than opinion-based.
Authors 4
-
Instituto Murciano de Investigación Biosanitaria
Affiliation as printed
Murcia Institute for Biomedical Research (IMIB)
-
David Collins. Wheeler corresponding
Affiliation as printed
University College London
-
Affiliation as printed
Angiology and Internal Intensive Care Medicine, RWTH Aachen University
-
University of British Columbia · Provincial Health Services Authority · BC Renal
Affiliation as printed
BC Renal, Provincial Health Services Authority
University of British Columbia
Cited by 0 stored of 0
No patents citing this paper on Lens.org (checked 2026-10-06).
References 6
-
W4387296715details pending0citations
6 results